Genomics BioSci & Tech. Co.,Ltd. (TPE:4195)
Taiwan · Delayed Price · Currency is TWD 16.30
+0.45 (2.84%)
At close: Oct 8, 2026
Genomics BioSci & Tech. Market Cap
Genomics BioSci & Tech. has a market cap or net worth of 1.3 billion as of October 9, 2026. It is the 31,843rd most valuable company in the world and the 1,904th biggest in Taiwan. Its market cap has decreased by 33.34% in one year.
Market Cap
1.30B
Enterprise Value
1.75B
Revenue
718.16M
Global Rank
Country Rank
#1,904 Taiwan
PE Ratio
n/a
ChartMarket Cap Chart
Since December 16, 2013, Genomics BioSci & Tech.'s market cap has decreased from 1.58B to 1.30B, a decrease of -17.53%. That is a compound annual growth rate of -1.49%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 8, 2026 | 1.30B | -29.96% |
| Dec 31, 2025 | 1.86B | 33.85% |
| Dec 31, 2024 | 1.39B | -7.69% |
| Dec 29, 2023 | 1.51B | 19.84% |
| Dec 30, 2022 | 1.26B | 11.67% |
| Dec 30, 2021 | 1.13B | 0.78% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| HanchorBio | 23.31B |
| Elixiron Immunotherapeutics (Cayman) Limited | 19.60B |
| Intelligene | 7.92B |
| Obigen Pharma | 7.91B |
| Uwell Biopharma | 5.70B |
| Tripartite Therapeutics | 5.36B |
| Pet Pharm Biotech | 3.04B |
| BIONET Therapeutics | 2.69B |